These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3032804)

  • 21. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(3):164-282. PubMed ID: 4212341
    [No Abstract]   [Full Text] [Related]  

  • 22. Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis.
    Ruhno J; Denburg J; Dolovich J
    J Allergy Clin Immunol; 1988 Mar; 81(3):570-4. PubMed ID: 2831262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations.
    Pearce FL; Al-Laith M; Bosman L; Brostoff J; Cunniffe TM; Flint KC; Hudspith BN; Jaffar ZH; Johnson NM; Kassessinoff TA
    Drugs; 1989; 37 Suppl 1():37-43; discussion 69-77. PubMed ID: 2474428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.
    Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Lau HY; Liu WL; Pearce FL
    Thorax; 1988 Oct; 43(10):756-61. PubMed ID: 2462755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nedocromil sodium on antigen-induced airway responses in allergic sheep.
    Abraham WM
    Drugs; 1989; 37 Suppl 1():78-86; discussion 127-36. PubMed ID: 2547569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of fog-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in intrinsic asthma: a double-blind, placebo-controlled study.
    del Bufalo C; Fasano L; Patalano F; Gunella G
    Respiration; 1989; 55(3):181-5. PubMed ID: 2554440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassessment of mast cell stabilizers in the treatment of respiratory disease.
    Church MK
    Ann Allergy; 1989 Mar; 62(3):215-21. PubMed ID: 2538097
    [No Abstract]   [Full Text] [Related]  

  • 28. Disodium cromoglycate in allergic respiratory disease.
    Br Med J; 1972 Apr; 2(5806):159-61. PubMed ID: 4622784
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of nedocromil sodium on mediator release from mast cells.
    Pearce FL
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):155-8. PubMed ID: 7687609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.
    el Hennawi M
    Br J Ophthalmol; 1994 May; 78(5):365-9. PubMed ID: 8025071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium.
    Bissonnette EY; Enciso JA; Befus AD
    Clin Exp Immunol; 1995 Oct; 102(1):78-84. PubMed ID: 7554404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Membrane stabilizers (chromones and ketotifen)].
    Mancel E; Drouet M; Sabbah A
    Allerg Immunol (Paris); 1999 Apr; 31(4):103-5. PubMed ID: 10370721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of nedocromil sodium, sodium cromoglycate and codeine phosphate on citric acid-induced cough in dogs.
    Jackson DM
    Br J Pharmacol; 1988 Mar; 93(3):609-12. PubMed ID: 2836011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma.
    Cairns H; Cox D; Gould KJ; Ingall AH; Suschitzky JL
    J Med Chem; 1985 Dec; 28(12):1832-42. PubMed ID: 2999403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma.
    Williams AJ; Stableforth D
    Eur J Respir Dis Suppl; 1986; 147():340-3. PubMed ID: 3021502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Airways obstruction and disodium-cromoglycate--a new therapeutic principle (Clinical aspects) (author's transl)].
    Schmidt OP; Primer G; Anolick GP
    Med Klin; 1975 Aug; 70(32-33):1297-1303. PubMed ID: 818492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report.
    van As A; Chick TW; Bodman SF; Storms WW; Nathan RA; Selner JC; Koepke JW; Townley RG; Bewtra AK; Nair N
    Eur J Respir Dis Suppl; 1986; 147():143-8. PubMed ID: 3021488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children.
    de Benedictis FM; Tuteri G; Bertotto A; Bruni L; Vaccaro R
    J Allergy Clin Immunol; 1994 Oct; 94(4):684-8. PubMed ID: 7930301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats.
    Johnson HG; van Hout CA
    Int Arch Allergy Appl Immunol; 1976; 50(4):446-53. PubMed ID: 55394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nedocromil sodium.
    Parish RC; Miller LJ
    Ann Pharmacother; 1993 May; 27(5):599-606. PubMed ID: 8394165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.